The FDA has approved the NovoTTF-100L System (Novocure) in combination with pemetrexed plus platinum-based chemotherapy for the first-line treatment of unresectable, locally advanced or metastatic, malignant pleural mesothelioma.
Women are more likely to be symptomatic, have greater odds of frequent, severe acute exacerbations.
The cardiopulmonary reserve index is an effective predictor of prognosis in patients with pulmonary hypertension, particularly when pulmonary hypertension is caused by left heart disease.
When used as needed, the combination of budesonide-formoterol was found to be superior to albuterol for the prevention of asthma exacerbations in patients with mild asthma.
Patients with COPD who have the most severe airflow obstructions according to the GOLD strategy document had more exacerbations than those with less severe obstructions, and were more likely to be treated with both systemic corticosteroids and antibiotics.
Researchers examined whether obesity is a factor in the mortality of patients with acute respiratory failure that requires intubation.
Benralizumab has been found to be associated with a reduction in oral corticosteroid (OCS) use while maintaining asthma control for patients with OCS-dependent severe asthma.
Individuals with moderate to very severe COPD and cardiovascular risk factors did not have an increased risk for all-cause mortality or major adverse cardiovascular event occurrence with the use of aclidinium.
Researchers compared lung function improvements within the combination subgroups of high/low eosinophil levels and high/low FEV1 reversibility in patients with moderate to severe asthma treated with omalizumab vs patients who took placebo.
Investigators sought to determine a link between baseline blood eosinophil counts and certain biomarkers and observed that mepolizumab-treated individuals with elevated baseline levels of eosinophil-derived neurotoxin experienced the greatest reduction in exacerbation rates.
